Raghu Kalluri, M.D., Ph.D.

Peer-Reviewed Articles

1. Luo X, McAndrews KM, Arian KA, Morse SJ, Boeker V, Kumbhar SV, Hu Y, Mahadevan KK, Church KA, Chitta S, Ryujin NT, Hensel J, Dai J, Dowlatshahi DP, Sugimoto H, Kirtley ML, LeBleu VS, Shalapour S, Simmons JH, Kalluri R. Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity. J Control Release 374(None):550-562, 2024. PMID: 39146981.
2. Kapoor KS, Harris K, Arian KA, Ma L, Schueng Zancanela B, Church KA, McAndrews KM, Kalluri R. High throughput and rapid isolation of extracellular vesicles and exosomes with purity using size exclusion liquid chromatography. Bioact Mater 40(None):683-695, 2024. PMID: 39290685.
3. Zhou X, LeBleu VS, Fletcher-Sananikone E, Kim J, Dai J, Li B, Wu CC, Sugimoto H, Miyake T, Becker LM, Volpert OV, Lawson E, Espinosa Da Silva C, Patel SI, Kizu A, Ehsanipour EA, Sha D, Karam JA, McAndrews KM, Kalluri R. Vascular heterogeneity of tight junction Claudins guides organotropic metastasis. Nat Cancer 5(9):1371-1389, 2024. PMID: 39289595.
4. Mahadevan KK, Dyevoich AM, Chen Y, Li B, Sugimoto H, Sockwell AM, McAndrews KM, Sthanam LK, Wang H, Shalapour S, Watowich SS, Kalluri R. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. Science 384(6703):eadh4567, 2024. PMID: 38935717.
5. LeBleu VS, Kanasaki K, Lovisa S, Alge JL, Kim J, Chen Y, Teng Y, Gerami-Naini B, Sugimoto H, Kato N, Revuelta I, Grau N, Sleeman JP, Taduri G, Kizu A, Rafii S, Hochedlinger K, Quaggin SE, Kalluri R. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome. Life Sci Alliance 7(6), 2024. PMID: 38561223.
6. Kapoor KS, Kong S, Sugimoto H, Guo W, Boominathan V, Chen YL, Biswal SL, Terlier T, McAndrews KM, Kalluri R. Single Extracellular Vesicle Imaging and Computational Analysis Identifies Inherent Architectural Heterogeneity. ACS Nano 18(18):11717-11731, 2024. PMID: 38651873.
7. Li B, Kugeratski FG, Kalluri R. A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes. Elife 12, 2024. PMID: 38529947.
8. Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy SV, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD, Hebrok M, Hansen K, Moses HL, Weaver VM. Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med 30(3):908, 2024. PMID: 38017076.
9. Welsh, JA, Goberdhan, DC, O'Driscoll, L, Buzas, E, Blenkiron, C, Bussolati, B, Cai, H, Di Vizio, D, Driedonks, TA, Erdbrügger, U, Falcon-Perez, JM, Fu, QL, Hill, AF, Lenassi, M, Lim, SK, Mahoney, Mỹ, Mohanty, S, Möller, A, Nieuwland, R, Ochiya, T, Sahoo, S, Torrecilhas, AC, Zheng, L, Zijlstra, A, Abuelreich, S, Bagabas, R, Bergese, P, Bridges, EM, Brucale, M, Burger, D, Carney, RP, Cocucci, E, Crescitelli, R, Hanser, E, Harris, AL, Haughey, NJ, Hendrix, A, Ivanov, AR, Jovanovic-Talisman, T, Kruh-Garcia, NA, Faustino, VL, Kyburz, D, Lässer, C, Lennon, KM, Lötvall, J, Esmaeili, R, Kalluri, R, Llorente, A, Milutinovic, B, Naora, H. Minimal information for studies of extracellular vesicles (MISEV2023). Journal of Extracellular Vesicles 13(2), 2024. PMID: 38326288.
10. Thorlacius-Ussing J, Jensen C, Nissen NI, Cox TR, Kalluri R, Karsdal M, Willumsen N. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J Pathol 262(1):22-36, 2024. PMID: 37728068.
11. Kapoor KS, Kong S, Sugimoto H, Guo W, Boominathan V, Chen YL, Biswal SL, Terlier T, McAndrews KM, Kalluri R. Single extracellular vesicle imaging and computational analysis identifies inherent architectural heterogeneity. bioRxiv None(None):None, 2023. PMID: 38168235.
12. Kugeratski FG, LeBleu VS, Dowlatshahi DP, Sugimoto H, Arian KA, Fan Y, Huang L, Wells D, Lilla S, Hodge K, Zanivan S, McAndrews KM, Kalluri R. Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity. bioRxiv None(None):None, 2023. PMID: 37961535.
13. Ferreira D, Santos-Pereira C, Costa M, Afonso J, Yang S, Hensel J, McAndrews KM, Longatto-Filho A, Fernandes R, Melo JB, Baltazar F, Moreira JN, Kalluri R, Rodrigues LR. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomater Adv 154:213643, 2023. PMID: 37778291.
14. Mahadevan KK, LeBleu VS, Ramirez EV, Chen Y, Li B, Sockwell AM, Gagea M, Sugimoto H, Sthanam LK, Tampe D, Zeisberg M, Ying H, Jain AK, DePinho RA, Maitra A, McAndrews KM, Kalluri R. Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8(+) T cells. Dev Cell 58(17):1562-1577.e8, 2023. PMID: 37625403.
15. Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, Sockwell AM, Kirtley ML, Morse SJ, Moreno Diaz BA, Kim MP, Feng N, Lopez AM, Guerrero PA, Paradiso F, Sugimoto H, Arian KA, Ying H, Barekatain Y, Sthanam LK, Kelly PJ, Maitra A, Heffernan TP, Kalluri R. KRAS(G12D) inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8(+) T cells. Cancer Cell 41(9):1606-1620.e8, 2023. PMID: 37625401.
16. LeBleu VS, Dai J, Tsutakawa S, MacDonald BA, Alge JL, Sund M, Xie L, Sugimoto H, Tainer J, Zon LI, Kalluri R. Identification of unique alpha4 chain structure and conserved antiangiogenic activity of alpha3NC1 type IV collagen in zebrafish. Dev Dyn 252(7):1046-1060, 2023. e-Pub 2023. PMID: 37002899.
17. Iyer MR, Kalluri R. Nuclear Translocation Triggered at the Onset of Hearing in Cochlear Inner Hair Cells of Rats and Mice. J Assoc Res Otolaryngol 24(3):291-303, 2023. PMID: 36932316.
18. Iyer MR, Ventura C, Bronson D, Nowak N, Regalado K, Kalluri R. Isolating and Culturing Vestibular and Spiral Ganglion Somata from Neonatal Rodents for Patch-Clamp Recordings. J Vis Exp None(194):None, 2023. PMID: 37154564.
19. Bronson D, Kalluri R. Muscarinic Acetylcholine Receptors Modulate HCN Channel Properties in Vestibular Ganglion Neurons. J Neurosci 43(6):902-917, 2023. PMID: 36604171.
20. Haltom AR, Hassen WE, Hensel J, Kim J, Sugimoto H, Li B, McAndrews KM, Conner MR, Kirtley ML, Luo X, Xie B, Volpert OV, Olalekan S, Maltsev N, Basu A, LeBleu VS, Kalluri R. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma. Extracell Vesicle 1(None):None, 2022. PMID: 37503329.
21. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R. Author Correction: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 610(7932):E15-E17, 2022. PMID: 36198804.
22. Chen Y, Yang S, Tavormina J, Tampe D, Zeisberg M, Wang H, Mahadevan KK, Wu CJ, Sugimoto H, Chang CC, Jenq RR, McAndrews KM, Kalluri R. Oncogenic collagen I homotrimers from cancer cells bind to alpha3beta1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. Cancer Cell 40(8):818-834.e9, 2022. e-Pub 2022. PMID: 35868307.
23. Barekatain Y, Khadka S, Harris K, Delacerda J, Yan VC, Chen KC, Pham CD, Uddin MN, Avritcher R, Eisenberg EJ, Kalluri R, Millward SW, Muller FL. Quantification of Phosphonate Drugs by (1)H-(31)P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice. Anal Chem 94(28):10045-10053, 2022. e-Pub 2022. PMID: 35792073.
24. McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, Li B, Wang H, Miyake T, Correa de Sampaio P, Kirtley ML, Natale M, Wu CC, Sugimoto H, LeBleu VS, Kalluri R. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. Cancer Discov 12(6):1580-1597, 2022. e-Pub 2022. PMID: 35348629.
25. Salomon C, Das S, Erdbrugger U, Kalluri R, Kiang Lim S, Olefsky JM, Rice GE, Sahoo S, Andy Tao W, Vader P, Wang Q, Weaver AM. Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement. Endocr Rev 43(3):441-468, 2022. PMID: 35552682.
26. McAndrews KM, Miyake T, Ehsanipour EA, Kelly PJ, Becker LM, McGrail DJ, Sugimoto H, LeBleu VS, Ge Y, Kalluri R. Dermal alphaSMA(+) myofibroblasts orchestrate skin wound repair via beta1 integrin and independent of type I collagen production. EMBO J 41(7):e109470, 2022. e-Pub 2022. PMID: 35212000.
27. Kalluri ROR, Thotli LR, Gugamsetty B, Kotalo RG, Akkiraju B, Virupakshappa UK, Lingala SSR. An assessment of the impact of Indian summer monsoon droughts on atmospheric aerosols and associated radiative forcing at a semi-arid station in peninsular India. Sci Total Environ 813(None):152683, 2022. PMID: 34971683.
28. El-Shennawy L, Hoffmann AD, Dashzeveg NK, McAndrews KM, Mehl PJ, Cornish D, Yu Z, Tokars VL, Nicolaescu V, Tomatsidou A, Mao C, Felicelli CJ, Tsai CF, Ostiguin C, Jia Y, Li L, Furlong K, Wysocki J, Luo X, Ruivo CF, Batlle D, Hope TJ, Shen Y, Chae YK, Zhang H, LeBleu VS, Shi T, Swaminathan S, Luo Y, Missiakas D, Randall GC, Demonbreun AR, Ison MG, Kalluri R, Fang D, Liu H. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun 13(1):405, 2022. e-Pub 2022. PMID: 35058437.
29. Ruivo CF, Bastos N, Adem B, Batista I, Duraes C, Melo CA, Castaldo SA, Campos-Laborie F, Moutinho-Ribeiro P, Morao B, Costa-Pinto A, Silva S, Osorio H, Ciordia S, Costa JL, Goodrich D, Cavadas B, Pereira L, Kouzarides T, Macedo G, Maio R, Carneiro F, Cravo M, Kalluri R, Machado JC, Melo SA. Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression. Gut 71(10):2043-68, 2022. e-Pub 2022. PMID: 35012996.
30. Markowitz AL, Iyer MR, Kalluri R. Patch-clamp Recordings and Single Fiber Labeling from Spiral Ganglion Somata in Acutely Prepared Semi-intact Cochleae from Neonatal Rats. Bio Protoc 12(1):e4281, 2022. PMID: 35118173.
31. Chen Y, Yang S, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H, Kalluri R. Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta. Nat Commun 12(1):7199, 2021. e-Pub 2021. PMID: 34893625.
32. Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, Garcia de Herreros A, Goodall GJ, Hadjantonakis AK, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massague J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP, Sheng G. Author Correction: Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 22(12):834, 2021. PMID: 34654908.
33. Junaidi MAR, Sista H, Kalluri RCM, Rao YVD, Gokhale AGK. Simulation of non-Newtonian flow of blood in a modified laparoscopic forceps used in minimally invasive surgery. Comput Methods Biomech Biomed Engin 24(16):1794-1806, 2021. PMID: 34134562.
34. Zhou X, Kurywchak P, Wolf-Dennen K, Che SPY, Sulakhe D, D'Souza M, Xie B, Maltsev N, Gilliam TC, Wu CC, McAndrews KM, LeBleu VS, McConkey DJ, Volpert OV, Pretzsch SM, Czerniak BA, Dinney CP, Kalluri R. Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer. Mol Ther Methods Clin Dev 22:360-376, 2021. e-Pub 2021. PMID: 34514028.
35. McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R. Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer. Life Sci Alliance 4(9), 2021. e-Pub 2021. PMID: 34282051.
36. Barekatain Y, Ackroyd JJ, Yan VC, Khadka S, Wang L, Chen KC, Poral AH, Tran T, Georgiou DK, Arthur K, Lin YH, Satani N, Ballato ES, Behr EI, deCarvalho AC, Verhaak RGW, de Groot J, Huse JT, Asara JM, Kalluri R, Muller FL. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine. Nat Commun 12(1):4228, 2021. e-Pub 2021. PMID: 34244484.
37. McAndrews KM, Vazquez-Arreguin K, Kwak C, Sugimoto H, Zheng X, Li B, Kirtley ML, LeBleu VS, Kalluri R. alphaSMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression. Oncogene 40(26):4440-4452, 2021. e-Pub 2021. PMID: 34108617.
38. Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39(6):883, 2021. PMID: 34129825.
39. Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, Chin L, Filliol A, Wen W, Song X, Decker A, Worley J, Caviglia JM, Yu L, Yin D, Saito Y, Savage T, Wells RG, Mack M, Zender L, Arpaia N, Remotti HE, Rabadan R, Sims P, Leblond AL, Weber A, Riener MO, Stockwell BR, Gaublomme J, Llovet JM, Kalluri R, Michalopoulos GK, Seki E, Sia D, Chen X, Califano A, Schwabe RF. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39(6):866-882.e11, 2021. e-Pub 2021. PMID: 33930309.
40. Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D, Wirsik NM, Mehal A, Arpaia N, Seki E, Mack M, Zhu D, Sims PA, Kalluri R, Stanger BZ, Olive KP, Schmidt T, Wells RG, Mederacke I, Schwabe RF. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest 131(11), 2021. PMID: 33905375.
41. Kugeratski FG, Hodge K, Lilla S, McAndrews KM, Zhou X, Hwang RF, Zanivan S, Kalluri R. Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker. Nat Cell Biol 23(6):631-641, 2021. e-Pub 2021. PMID: 34108659.
42. Junaidi MAR, Kalluri RCM, Rao YVD, Gokhale AGK, Patel A. Design and fluid flow simulation of modified laparoscopic forceps. Comput Methods Biomech Biomed Engin 24(8):844-863, 2021. PMID: 33305607.
43. Zhou X, Xiao F, Sugimoto H, Li B, McAndrews KM, Kalluri R. Acute Kidney Injury Instigates Malignant Renal Cell Carcinoma via CXCR2 in Mice with Inactivated Trp53 and Pten in Proximal Tubular Kidney Epithelial Cells. Cancer Res 81(10):2690-2702, 2021. e-Pub 2021. PMID: 33558337.
44. Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, LeBleu VS, McAndrews KM, Kalluri R. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J 35(5):e21557, 2021. PMID: 33855751.
45. Carstens JL, Yang S, Correa de Sampaio P, Zheng X, Barua S, McAndrews KM, Rao A, Burks JK, Rhim AD, Kalluri R. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer. Cell Rep 35(2):108990, 2021. PMID: 33852841.
46. Chen Y, Kim J, Yang S, Wang H, Wu CJ, Sugimoto H, LeBleu VS, Kalluri R. Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39(4):548-565.e6, 2021. e-Pub 2021. PMID: 33667385.
47. Parchem JG, Kanasaki K, Lee SB, Kanasaki M, Yang JL, Xu Y, Earl KM, Keuls RA, Gattone VH 2nd, Kalluri R. STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects. JCI Insight 6(2), 2021. e-Pub 2021. PMID: 33301424.
48. Kalluri ROR, Gugamsetty B, Tandule CR, Kotalo RG, Thotli LR, Rajuru RR, Palle SNR. Impact of aerosols on surface ozone during COVID-19 pandemic in southern India: A multi-instrumental approach from ground and satellite observations, and model simulations. J Atmos Sol Terr Phys 212(None):105491, 2021. PMID: 33318726.
49. McAndrews KM, Che SPY, LeBleu VS, Kalluri R. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity. J Biol Chem 296:100523, 2021. e-Pub 2021. PMID: 33711340.
50. Kalluri R. Similarities in the Biophysical Properties of Spiral-Ganglion and Vestibular-Ganglion Neurons in Neonatal Rats. Front Neurosci 15(None):710275, 2021. PMID: 34712112.
51. McAndrews KM, Chen Y, Kalluri R. Stromal Cells Exhibit Prevalent Genetic Aberrations in Colorectal Cancer. Cancer Cell 38(6):774-775, 2020. PMID: 33321084.
52. Hensel J, McAndrews KM, McGrail DJ, Dowlatshahi DP, LeBleu VS, Kalluri R. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses. Sci Rep 10(1):18377, 2020. e-Pub 2020. PMID: 33110184.
53. McAndrews KM, Kalluri R. A map of human breast cancer: new players in stromal-immune crosstalk. EMBO J 39(19):e106368, 2020. e-Pub 2020. PMID: 32909627.
54. Vickman R, Faget D, Beachy P, Beebe D, Bhowmick N, Cukierman E, Deng W, Granneman J, Kalluri R, Lau K, Lengyel E, Lundeberg J, Moscat J, Nelson P, Pietras K, Politi K, Pure E, Scherz-Shouval R, Sherman MM, Tuveson D, Weeraratna A, White R, Wong, Woodhous E, Zheng Y, Hayward S, Stewart S, Hidesheim J. Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget 11(40):3621-3632, 2020. PMID: 33088423.
55. McAndrews KM, Dowlatshahi DP, Dai J, Becker LM, Hensel J, Snowden LM, Leveille JM, Brunner MR, Holden KW, Hopkins NS, Harris AM, Kumpati J, Whitt MA, Lee JJ, Ostrosky-Zeichner LL, Papanna R, LeBleu VS, Allison JP, Kalluri R. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity. JCI Insight 5(18):None, 2020. e-Pub 2020. PMID: 32796155.
56. Markowitz AL, Kalluri R. Gradients in the biophysical properties of neonatal auditory neurons align with synaptic contact position and the intensity coding map of inner hair cells. Elife 9(None):None, 2020. PMID: 32639234.
57. Hou P, Kapoor A, Zhang Q, Li J, Wu CJ, Li J, Lan Z, Tang M, Ma X, Ackroyd JJ, Kalluri R, Zhang J, Jiang S, Spring DJ, Wang YA, DePinho RA. Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer. Cancer Discov 10(7):1058-1077, 2020. e-Pub 2020. PMID: 32341020.
58. Menendez L, Trecek T, Gopalakrishnan S, Tao L, Markowitz AL, Yu HV, Wang X, Llamas J, Huang C, Lee J, Kalluri R, Ichida J, Segil N. Generation of inner ear hair cells by direct lineage conversion of primary somatic cells. Elife 9(None):None, 2020. PMID: 32602462.
59. Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, Taduri G, Lawson E, Dewar R, Revuelta I, Kato N, Wu CJ, Bassett RL Jr, Putluri N, Zeisberg M, Zeisberg EM, LeBleu VS, Kalluri R. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal 13(635):None, 2020. e-Pub 2020. PMID: 32518142.
60. Becker LM, O'Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S, McAndrews KM, Zielinski R, Lorenzi PL, Zeisberg M, Raza S, LeBleu VS, Kalluri R. Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer. Cell Rep 31(9):107701, 2020. PMID: 32492417.
61. Kalluri R. Isaiah Joshua ('Josh') Fidler 1936-2020. Nat Cancer 1(6):573-574, 2020. PMID: 35121977.
62. Parchem JG, Brock CO, Chen HY, Kalluri R, Barton JR, Sibai BM. Placental Growth Factor and the Risk of Adverse Neonatal and Maternal Outcomes. Obstet Gynecol 135(3):665-673, 2020. PMID: 32028495.
63. Sudhakar A, Nyberg P, Keshamouni VG, Mannam AP, Li J, Sugimoto H, Cosgrove D, Kalluri R. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 130(1):552, 2020. PMID: 31895054.
64. Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautes-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549-555, 2020. e-Pub 2020. PMID: 31942075.
65. McGrail DJ, Dai J, McAndrews KM, Kalluri R. Enacting national social distancing policies corresponds with dramatic reduction in COVID19 infection rates. PLoS One 15(7):e0236619, 2020. e-Pub 2020. PMID: 32730356.
66. McAndrews KM, LeBleu VS, Kalluri R. SIRT1 Regulates Lysosome Function and Exosome Secretion. Dev Cell 49(3):302-303, 2019. PMID: 31063745.
67. McAndrews KM, Kalluri R. Nischarin Regulates Secretion of Exosomes and Cancer Progression. Cancer Res 79(9):2099-2101, 2019. PMID: 31043427.
68. Ventura CM, Kalluri R. Enhanced Activation of HCN Channels Reduces Excitability and Spike-Timing Regularity in Maturing Vestibular Afferent Neurons. J Neurosci 39(15):2860-2876, 2019. PMID: 30696730.
69. LeBleu VS, Kalluri R. Exosomes Exercise Inhibition of Anti-Tumor Immunity during Chemotherapy. Immunity 50(3):547-549, 2019. PMID: 30893584.
70. Jang SC, Crescitelli R, Cvjetkovic A, Belgrano V, Olofsson Bagge R, Sundfeldt K, Ochiya T, Kalluri R, Lotvall J. Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma. J Extracell Vesicles 8(1):1635420, 2019. e-Pub 2019. PMID: 31497264.
71. Chen Y, Keskin D, Sugimoto H, Kanasaki K, Phillips PE, Bizarro L, Sharpe A, LeBleu VS, Kalluri R. Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis. PLoS Biol 16(12):e2005907, 2018. e-Pub 2018. PMID: 30592710.
72. Parchem JG, Kanasaki K, Kanasaki M, Sugimoto H, Xie L, Hamano Y, Lee SB, Gattone VH, Parry S, Strauss JF, Garovic VD, McElrath TF, Lu KH, Sibai BM, LeBleu VS, Carmeliet P, Kalluri R. Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. J Clin Invest 128(11):5008-5017, 2018. e-Pub 2018. PMID: 30179860.
73. Eikesdal HP, Becker LM, Teng Y, Kizu A, Carstens JL, Kanasaki K, Sugimoto H, LeBleu VS, Kalluri R. BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis. Mol Cancer Res 16(10):1568-1578, 2018. e-Pub 2018. PMID: 29934328.
74. Chen Y, LeBleu VS, Carstens JL, Sugimoto H, Zheng X, Malasi S, Saur D, Kalluri R. Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med 10(10):None, 2018. e-Pub 2018. PMID: 30120146.
75. Xu X, Tan X, Tampe B, Wilhelmi T, Hulshoff MS, Saito S, Moser T, Kalluri R, Hasenfuss G, Zeisberg EM, Zeisberg M. High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis. Nat Commun 9(1):3509, 2018. e-Pub 2018. PMID: 30158531.
76. Tampe B, Tampe D, Nyamsuren G, Klopper F, Rapp G, Kauffels A, Lorf T, Zeisberg EM, Muller GA, Kalluri R, Hakroush S, Zeisberg M. Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure. J Clin Invest 128(7):3053-3070, 2018. e-Pub 2018. PMID: 29664738.
77. Lovisa S, Kalluri R. Fatty Acid Oxidation Regulates the Activation of Endothelial-to-Mesenchymal Transition. Trends Mol Med 24(5):432-434, 2018. e-Pub 2018. PMID: 29573973.
78. Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri R. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3(8):None, 2018. e-Pub 2018. PMID: 29669940.
79. Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer 18(2):128-134, 2018. e-Pub 2018. PMID: 29326430.
80. Jiao J, Gonzalez A, Stevenson HL, Gagea M, Sugimoto H, Kalluri R, Beretta L. Depletion of S100A4(+) stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. Exp Mol Med 50(1):e422, 2018. e-Pub 2018. PMID: 29303514.
81. Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borras FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MA, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Gorecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzas EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekstrom K, El Andaloussi S, Elie-Caille C, Erdbrugger U, Falcon-Perez JM, Fatima F, Fish JE, Flores-Bellver M, Forsonits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gamez-Valero A, Gardiner C, Gartner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Gorgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanovic MM, Kovacs AF, Kramer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lasser C, Laurent LC, Lavieu G, Lazaro-Ibanez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Line A, Linnemannstons K, Llorente A, Lombard CA, Lorenowicz MJ, Lorincz AM, Lotvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Moller A, Moller Jorgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Ostergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saa P, Sahoo S, Salas-Huenuleo E, Sanchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schoyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sodar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot E, Verweij FJ, Vestad B, Vinas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yanez-Mo M, Yin H, Yuana Y, Zappulli V, Zarubova J, Zekas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750, 2018. e-Pub 2018. PMID: 30637094.
82. Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, Dunner K, Zal MA, Burks JK, Gumin J, Nwajei F, Rezavanian A, Zhou S, Rao G, Sawaya R, Fuller GN, Huse JT, Antel JP, Li S, Cooper L, Sulman EP, Chen C, Geula C, Kalluri R, Zal T, Heimberger AB. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology 7(4):e1412909, 2018. e-Pub 2018. PMID: 29632728.
83. Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, Daaboul G, Devitt A, Falcon-Perez JM, Gardiner C, Gustafson D, Harrison P, Helmbrecht C, Hendrix A, Hill A, Hoffman A, Jones JC, Kalluri R, Kang JY, Kirchner B, Lasser C, Lawson C, Lenassi M, Levin C, Llorente A, Martens-Uzunova ES, Moller A, Musante L, Ochiya T, Pink RC, Tahara H, Wauben MHM, Webber JP, Welsh JA, Witwer KW, Yin H, Nieuwland R. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J Extracell Vesicles 7(1):1473707, 2018. PMID: 31162490.
84. Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF. Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Res 77(21):5808-5819, 2017. e-Pub 2017. PMID: 28855213.
85. Pickup MW, Owens P, Gorska AE, Chytil A, Ye F, Shi C, Weaver VM, Kalluri R, Moses HL, Novitskiy SV. Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells. Cancer Immunol Res 5(9):718-729, 2017. e-Pub 2017. PMID: 28775207.
86. Abdala C, Kalluri R. Towards a joint reflection-distortion otoacoustic emission profile: Results in normal and impaired ears. J Acoust Soc Am 142(2):812, 2017. PMID: 28863614.
87. Megjhani M, Correa de Sampaio P, Leigh Carstens J, Kalluri R, Roysam B. Morphologically constrained spectral unmixing by dictionary learning for multiplex fluorescence microscopy. Bioinformatics 33(14):2182-2190, 2017. e-Pub 2017. PMID: 28334208.
88. Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546(7659):498-503, 2017. e-Pub 2017. PMID: 28607485.
89. Kalluri R, Monges-Hernandez M. Spatial Gradients in the Size of Inner Hair Cell Ribbons Emerge Before the Onset of Hearing in Rats. J Assoc Res Otolaryngol 18(3):399-413, 2017. PMID: 28361374.
90. Kurywchak P, Kalluri R. An evolving function of DNA-containing exosomes in chemotherapy-induced immune response. Cell Res 27(6):722-723, 2017. e-Pub 2017. PMID: 28524163.
91. Carstens JL, Correa de Sampaio P, Yang D, Barua S, Wang H, Rao A, Allison JP, LeBleu VS, Kalluri R. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun 8(None):15095, 2017. e-Pub 2017. PMID: 28447602.
92. Yang S, Che SP, Kurywchak P, Tavormina JL, Gansmo LB, Correa de Sampaio P, Tachezy M, Bockhorn M, Gebauer F, Haltom AR, Melo SA, LeBleu VS, Kalluri R. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Cancer Biol Ther 18(3):158-165, 2017. e-Pub 2017. PMID: 28121262.
93. Tampe B, Steinle U, Tampe D, Carstens JL, Korsten P, Zeisberg EM, Muller GA, Kalluri R, Zeisberg M. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression. Kidney Int 91(1):157-176, 2017. e-Pub 2016. PMID: 27692563.
94. Kalluri ROR, Gugamsetty B, Kotalo RG, Nagireddy SKR, Tandule CR, Thotli LR, Rajuru Ramakrishna R, Surendranair SB. Direct radiative forcing properties of atmospheric aerosols over semi-arid region, Anantapur in India. Sci Total Environ 566-567(None):1002-1013, 2016. PMID: 27344510.
95. Hight AE, Kalluri R. A biophysical model examining the role of low-voltage-activated potassium currents in shaping the responses of vestibular ganglion neurons. J Neurophysiol 116(2):503-21, 2016. PMID: 27121577.
96. Laklai H, Miroshnikova YA, Pickup MW, Collisson EA, Kim GE, Barrett AS, Hill RC, Lakins JN, Schlaepfer DD, Mouw JK, LeBleu VS, Roy N, Novitskiy SV, Johansen JS, Poli V, Kalluri R, Iacobuzio-Donahue CA, Wood LD, Hebrok M, Hansen K, Moses HL, Weaver VM. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med 22(5):497-505, 2016. e-Pub 2016. PMID: 27089513.
97. Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri R. Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. Cancer Cell 28(6):831-833, 2015. e-Pub 2015. PMID: 28843279.
98. Cleland TP, Schroeter ER, Zamdborg L, Zheng W, Lee JE, Tran JC, Bern M, Duncan MB, Lebleu VS, Ahlf DR, Thomas PM, Kalluri R, Kelleher NL, Schweitzer MH. Mass Spectrometry and Antibody-Based Characterization of Blood Vessels from Brachylophosaurus canadensis. J Proteome Res 14(12):5252-62, 2015. e-Pub 2015. PMID: 26595531.
99. Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527(7579):525-530, 2015. e-Pub 2015. PMID: 26560028.
100. Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, Nischal H, Allison JP, Zeisberg M, Kalluri R. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21(9):998-1009, 2015. e-Pub 2015. PMID: 26236991.
101. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523(7559):177-82, 2015. e-Pub 2015. PMID: 26106858.
102. Zhang J, Jiao J, Cermelli S, Muir K, Jung KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R, Beretta L. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. Cancer Res 75(9):1859-67, 2015. e-Pub 2015. PMID: 25769721.
103. Leveille N, Melo CA, Rooijers K, Diaz-Lagares A, Melo SA, Korkmaz G, Lopes R, Moqadam FA, Maia AR, Wijchers PJ, Geeven G, den Boer ML, Kalluri R, de Laat W, Esteller M, Agami R. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun 6(None):6520, 2015. e-Pub 2015. PMID: 25813522.
104. Xu X, Tan X, Tampe B, Nyamsuren G, Liu X, Maier LS, Sossalla S, Kalluri R, Zeisberg M, Hasenfuss G, Zeisberg EM. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis. Cardiovasc Res 105(3):279-91, 2015. e-Pub 2015. PMID: 25616414.
105. Xu X, Friehs I, Zhong Hu T, Melnychenko I, Tampe B, Alnour F, Iascone M, Kalluri R, Zeisberg M, Del Nido PJ, Zeisberg EM. Endocardial fibroelastosis is caused by aberrant endothelial to mesenchymal transition. Circ Res 116(5):857-66, 2015. e-Pub 2015. PMID: 25587097.
106. Keskin D, Kim J, Cooke VG, Wu CC, Sugimoto H, Gu C, De Palma M, Kalluri R, LeBleu VS. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. Cell Rep 10(7):1066-81, 2015. e-Pub 2015. PMID: 25704811.
107. Tampe B, Tampe D, Zeisberg EM, Muller GA, Bechtel-Walz W, Koziolek M, Kalluri R, Zeisberg M. Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease. EBioMedicine 2(1):19-36, 2015. PMID: 25717475.
108. Kalluri R, Abdala C. Stimulus-frequency otoacoustic emissions in human newborns. J Acoust Soc Am 137(1):EL78-84, 2015. PMID: 25618103.
109. Abdala C, Kalluri R. Exploiting Dual Otoacoustic Emission Sources. AIP Conf Proc 1703(None):None, 2015. PMID: 27695142.
110. Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 26(5):707-21, 2014. e-Pub 2014. PMID: 25446899.
111. Miyake T, Kalluri R. Cardiac biology: Cell plasticity helps hearts to repair. Nature 514(7524):575-6, 2014. e-Pub 2014. PMID: 25317554.
112. Zeisberg M, Tampe B, LeBleu V, Tampe D, Zeisberg EM, Kalluri R. Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure. Am J Pathol 184(10):2687-98, 2014. e-Pub 2014. PMID: 25111226.
113. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A, Domingos Chinen LT, Rocha RM, Asara JM, Kalluri R. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16(10):992-1003, 1-15, 2014. e-Pub 2014. PMID: 25241037.
114. Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. Int J Cardiol 176(1):99-109, 2014. e-Pub 2014. PMID: 25049013.
115. Ozdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri R. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25(6):719-34, 2014. e-Pub 2014. PMID: 24856586.
116. Tampe B, Tampe D, Muller CA, Sugimoto H, LeBleu V, Xu X, Muller GA, Zeisberg EM, Kalluri R, Zeisberg M. Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis. J Am Soc Nephrol 25(5):905-12, 2014. e-Pub 2014. PMID: 24480825.
117. Carstens JL, Lovisa S, Kalluri R. Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch. J Clin Invest 124(4):1458-60, 2014. e-Pub 2014. PMID: 24642461.
118. Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A, Kalluri R. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289(7):3869-75, 2014. e-Pub 2014. PMID: 24398677.
119. Ayala de la Pena F, Kanasaki K, Kanasaki M, Vong S, Rovira C, Kalluri R. Specific activation of K-RasG12D allele in the bladder urothelium results in lung alveolar and vascular defects. PLoS One 9(4):e95888, 2014. e-Pub 2014. PMID: 24760005.
120. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19(8):1047-53, 2013. e-Pub 2013. PMID: 23817022.
121. Plaks V, Rinkenberger J, Dai J, Flannery M, Sund M, Kanasaki K, Ni W, Kalluri R, Werb Z. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci U S A 110(27):11109-14, 2013. e-Pub 2013. PMID: 23776237.
122. Duncan MB, Yang C, Tanjore H, Boyle PM, Keskin D, Sugimoto H, Zeisberg M, Olsen BR, Kalluri R. Type XVIII collagen is essential for survival during acute liver injury in mice. Dis Model Mech 6(4):942-51, 2013. e-Pub 2013. PMID: 23580202.
123. Kalluri R, Shera CA. Measuring stimulus-frequency otoacoustic emissions using swept tones. J Acoust Soc Am 134(1):356-68, 2013. PMID: 23862813.
124. Kanasaki K, Yu W, von Bodungen M, Larigakis JD, Kanasaki M, Ayala de la Pena F, Kalluri R, Hill WG. Loss of beta1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype. FASEB J 27(5):1950-61, 2013. e-Pub 2013. PMID: 23395910.
125. Kalluri RK, Biener MM, Suss ME, Merrill MD, Stadermann M, Santiago JG, Baumann TF, Biener J, Striolo A. Unraveling the potential and pore-size dependent capacitance of slit-shaped graphitic carbon pores in aqueous electrolytes. Phys Chem Chem Phys 15(7):2309-20, 2013. PMID: 23295944.
126. Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA, Elkon R, Melo SA, Leveille N, Kalluri R, de Laat W, Agami R. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49(3):524-35, 2013. e-Pub 2012. PMID: 23273978.
127. Borges FT, Melo SA, Ozdemir BC, Kato N, Revuelta I, Miller CA, Gattone VH 2nd, LeBleu VS, Kalluri R. TGF-beta1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 24(3):385-92, 2013. PMID: 23274427.
128. LeBleu VS, Teng Y, O'Connell JT, Charytan D, Muller GA, Muller CA, Sugimoto H, Kalluri R. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19(2):227-31, 2013. e-Pub 2013. PMID: 23353556.
129. Melo SA, Kalluri R. miR-29b moulds the tumour microenvironment to repress metastasis. Nat Cell Biol 15(2):139-40, 2013. PMID: 23377028.
130. Bronnum H, Andersen DC, Schneider M, Sandberg MB, Eskildsen T, Nielsen SB, Kalluri R, Sheikh SP. miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1. PLoS One 8(2):e56280, 2013. e-Pub 2013. PMID: 23441172.
131. Fan X, Li Q, Pisarek-Horowitz A, Rasouly HM, Wang X, Bonegio RG, Wang H, McLaughlin M, Mangos S, Kalluri R, Holzman LB, Drummond IA, Brown D, Salant DJ, Lu W. Inhibitory effects of Robo2 on nephrin: a crosstalk between positive and negative signals regulating podocyte structure. Cell Rep 2(1):52-61, 2012. e-Pub 2012. PMID: 22840396.
132. Melo SA, Kalluri R. Angiogenesis is controlled by miR-27b associated with endothelial tip cells. Blood 119(11):2439-40, 2012. PMID: 22422815.
133. Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W Jr, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18(3):396-404, 2012. e-Pub 2012. PMID: 22306733.
134. Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, Teng Y, Duncan MB, Xie L, Maeda G, Vong S, Sugimoto H, Rocha RM, Damascena A, Brentani RR, Kalluri R. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21(1):66-81, 2012. PMID: 22264789.
135. Ho DN, Kohler N, Sigdel A, Kalluri R, Morgan JR, Xu C, Sun S. Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles. Theranostics 2(1):66-75, 2012. e-Pub 2012. PMID: 22272220.
136. LeBleu VS, Kalluri R. Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int 80(11):1119-21, 2011. PMID: 22083636.
137. Vong S, Kalluri R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer 2(12):1139-45, 2011. PMID: 22866205.
138. Joris PX, Bergevin C, Kalluri R, Mc Laughlin M, Michelet P, van der Heijden M, Shera CA. Frequency selectivity in Old-World monkeys corroborates sharp cochlear tuning in humans. Proc Natl Acad Sci U S A 108(42):17516-20, 2011. PMID: 21987783.
139. O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR, Resnick MB, Neilson EG, Zeisberg M, Kalluri R. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A 108(38):16002-7, 2011. e-Pub 2011. PMID: 21911392.
140. De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, Kalluri R, Normant E, Haigis MC, Manning BD, Wong KK, Macleod KF, Cichowski K. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20(3):400-13, 2011. PMID: 21907929.
141. Fawcett, JW, Kalluri, R, Duffield, JS, Silver, J. Starting the scar. Nature medicine 17(9), 2011. PMID: 21900921.
142. Medici D, Potenta S, Kalluri R. Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J 437(3):515-20, 2011. PMID: 21585337.
143. Xie L, Duncan MB, Pahler J, Sugimoto H, Martino M, Lively J, Mundel T, Soubasakos M, Rubin K, Takeda T, Inoue M, Lawler J, Hynes RO, Hanahan D, Kalluri R. Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc Natl Acad Sci U S A 108(24):9939-44, 2011. e-Pub 2011. PMID: 21622854.
144. Ayala de la Pena F, Kanasaki K, Kanasaki M, Tangirala N, Maeda G, Kalluri R. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 286(23):20778-87, 2011. e-Pub 2011. PMID: 21388952.
145. Abdala C, Dhar S, Kalluri R. Level dependence of distortion product otoacoustic emission phase is attributed to component mixing. J Acoust Soc Am 129(5):3123-33, 2011. PMID: 21568415.
146. Teng Y, Kanasaki K, Bardeesy N, Sugimoto H, Kalluri R. Deletion of Smad4 in fibroblasts leads to defective chondrocyte maturation and cartilage production in a TGFbeta type II receptor independent manner. Biochem Biophys Res Commun 407(4):633-9, 2011. e-Pub 2011. PMID: 21376704.
147. Yazdani AZ, Kalluri RM, Bagchi P. Tank-treading and tumbling frequencies of capsules and red blood cells. Phys Rev E Stat Nonlin Soft Matter Phys 83(4 Pt 2):046305, 2011. PMID: 21599293.
148. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller M. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 108(11):4394-9, 2011. e-Pub 2011. PMID: 21368194.
149. Bravo-Nuevo A, Sugimoto H, Iyer S, Fallon Z, Lucas JM, Kazerounian S, Prendergast GC, Kalluri R, Shapiro NI, Benjamin LE. RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice. Am J Pathol 178(1):245-52, 2011. e-Pub 2010. PMID: 21224061.
150. San Antonio JD, Schweitzer MH, Jensen ST, Kalluri R, Buckley M, Orgel JP. Dinosaur peptides suggest mechanisms of protein survival. PLoS One 6(6):e20381, 2011. e-Pub 2011. PMID: 21687667.
151. Charytan DM, Helfand AM, MacDonald BA, Cinelli A, Kalluri R, Zeisberg EM. Circulating endoglin concentration is not elevated in chronic kidney disease. PLoS One 6(8):e23718, 2011. e-Pub 2011. PMID: 21886815.
152. Shera CA, Bergevin C, Kalluri R, Laughlin MM, Michelet P, van der Heijden M, Joris PX. Otoacoustic Estimates of Cochlear Tuning: Testing Predictions in Macaque. AIP Conf Proc 1403(None):286-292, 2011. PMID: 24701000.
153. Abdala C, Dhar S, Kalluri R. Deviations from Scaling Symmetry in the Apical Half of the Human Cochlea. AIP Conf Proc 1403(None):483-488, 2011. PMID: 22745514.
154. LeBleu V, Sund M, Sugimoto H, Birrane G, Kanasaki K, Finan E, Miller CA, Gattone VH 2nd, McLaughlin H, Shield CF 3rd, Kalluri R. Identification of the NC1 domain of alpha3 chain as critical for alpha3alpha4alpha5 type IV collagen network assembly. J Biol Chem 285(53):41874-85, 2010. e-Pub 2010. PMID: 20847057.
155. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16(12):1400-6, 2010. e-Pub 2010. PMID: 21102460.
156. Kalluri R, Xue J, Eatock RA. Ion channels set spike timing regularity of mammalian vestibular afferent neurons. J Neurophysiol 104(4):2034-51, 2010. PMID: 20660422.
157. Force T, Bonow RO, Houser SR, Solaro RJ, Hershberger RE, Adhikari B, Anderson ME, Boineau R, Byrne BJ, Cappola TP, Kalluri R, LeWinter MM, Maron MS, Molkentin JD, Ommen SR, Regnier M, Tang WH, Tian R, Konstam MA, Maron BJ, Seidman CE. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation 122(11):1130-3, 2010. PMID: 20837938.
158. Hamano Y, Okude T, Shirai R, Sato I, Kimura R, Ogawa M, Ueda Y, Yokosuka O, Kalluri R, Ueda S. Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. J Am Soc Nephrol 21(9):1445-55, 2010. e-Pub 2010. PMID: 20616167.
159. Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R. Interstitial fluid: the overlooked component of the tumor microenvironment?. Fibrogenesis Tissue Repair 3(None):12, 2010. PMID: 20653943.
160. Keskin D, Kalluri R. NF-kappaB-induced chromatin remodeling regulates angiogenesis. Blood 116(3):312-3, 2010. PMID: 20651081.
161. Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 285(26):20202-12, 2010. e-Pub 2010. PMID: 20363741.
162. Bagchi P, Kalluri RM. Rheology of a dilute suspension of liquid-filled elastic capsules. Phys Rev E Stat Nonlin Soft Matter Phys 81(5 Pt 2):056320, 2010. PMID: 20866335.
163. Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16(5):544-50, 2010. e-Pub 2010. PMID: 20418885.
164. Lee SB, Wong AP, Kanasaki K, Xu Y, Shenoy VK, McElrath TF, Whitesides GM, Kalluri R. Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol 176(2):710-20, 2010. e-Pub 2010. PMID: 20075204.
165. LeBleu V, Sugimoto H, Mundel TM, Gerami-Naini B, Finan E, Miller CA, Gattone VH 2nd, Lu L, Shield CF 3rd, Folkman J, Kalluri R. Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol 20(11):2359-70, 2009. e-Pub 2009. PMID: 19833902.
166. Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 175(4):1371-3, 2009. PMID: 19729485.
167. Duncan MB, Kalluri R. Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis. Mol Interv 9(4):168-70, 2009. PMID: 19720748.
168. Bagchi P, Kalluri RM. Dynamics of nonspherical capsules in shear flow. Phys Rev E Stat Nonlin Soft Matter Phys 80(1 Pt 2):016307, 2009. PMID: 19658806.
169. Lee SB, Kanasaki K, Kalluri R. Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int 76(1):10-2, 2009. PMID: 19528989.
170. Romagnani P, Kalluri R. Possible mechanisms of kidney repair. Fibrogenesis Tissue Repair 2(1):3, 2009. PMID: 19558670.
171. Sohn RL, Huang P, Kawahara G, Mitchell M, Guyon J, Kalluri R, Kunkel LM, Gussoni E. A role for nephrin, a renal protein, in vertebrate skeletal muscle cell fusion. Proc Natl Acad Sci U S A 106(23):9274-9, 2009. e-Pub 2009. PMID: 19470472.
172. Chang SH, Kanasaki K, Gocheva V, Blum G, Harper J, Moses MA, Shih SC, Nagy JA, Joyce J, Bogyo M, Kalluri R, Dvorak HF. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res 69(10):4537-44, 2009. e-Pub 2009. PMID: 19435903.
173. Schweitzer MH, Zheng W, Organ CL, Avci R, Suo Z, Freimark LM, Lebleu VS, Duncan MB, Vander Heiden MG, Neveu JM, Lane WS, Cottrell JS, Horner JR, Cantley LC, Kalluri R, Asara JM. Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis. Science 324(5927):626-31, 2009. PMID: 19407199.
174. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res 68(23):9574-7, 2008. PMID: 19047131.
175. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19(12):2282-7, 2008. e-Pub 2008. PMID: 18987304.
176. Nyberg P, Xie L, Sugimoto H, Colorado P, Sund M, Holthaus K, Sudhakar A, Salo T, Kalluri R. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor. Exp Cell Res 314(18):3292-305, 2008. e-Pub 2008. PMID: 18775695.
177. Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M, Kalluri R. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity. Proc Natl Acad Sci U S A 105(39):15040-5, 2008. e-Pub 2008. PMID: 18818312.
178. Kalluri R, Han Y. Targeting TGF-beta and the extracellular matrix in Marfan's syndrome. Dev Cell 15(1):1-2, 2008. PMID: 18606132.
179. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453(7198):1117-21, 2008. e-Pub 2008. PMID: 18469803.
180. Zeisberg M, Kalluri R. Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci 13(None):6991-8, 2008. e-Pub 2008. PMID: 18508710.
181. Mundel TM, Yliniemi AM, Maeshima Y, Sugimoto H, Kieran M, Kalluri R. Type IV collagen alpha6 chain-derived noncollagenous domain 1 (alpha6(IV)NC1) inhibits angiogenesis and tumor growth. Int J Cancer 122(8):1738-44, 2008. PMID: 18074349.
182. Kalluri R, Kanasaki K. RNA interference: generic block on angiogenesis. Nature 452(7187):543-5, 2008. PMID: 18385725.
183. Lebleu VS, Sugimoto H, Miller CA, Gattone VH 2nd, Kalluri R. Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest 88(3):284-92, 2008. e-Pub 2008. PMID: 18180701.
184. Xie L, Palmsten K, MacDonald B, Kieran MW, Potenta S, Vong S, Kalluri R. Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med (Maywood) 233(2):155-62, 2008. PMID: 18222970.
185. Kanasaki K, Kanda Y, Palmsten K, Tanjore H, Lee SB, Lebleu VS, Gattone VH Jr, Kalluri R. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol 313(2):584-93, 2008. e-Pub 2007. PMID: 18082680.
186. Tanjore H, Zeisberg EM, Gerami-Naini B, Kalluri R. Beta1 integrin expression on endothelial cells is required for angiogenesis but not for vasculogenesis. Dev Dyn 237(1):75-82, 2008. PMID: 18058911.
187. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J. Modification of kidney barrier function by the urokinase receptor. Nat Med 14(1):55-63, 2008. e-Pub 2007. PMID: 18084301.
188. Cooke VG, Kalluri R. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis. Methods Enzymol 444(None):1-19, 2008. PMID: 19007658.
189. Kalluri R, Shera CA. Comparing stimulus-frequency otoacoustic emissions measured by compression, suppression, and spectral smoothing. J Acoust Soc Am 122(6):3562-75, 2007. PMID: 18247764.
190. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67(21):10123-8, 2007. PMID: 17974953.
191. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282(32):23337-47, 2007. e-Pub 2007. PMID: 17562716.
192. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13(8):952-61, 2007. e-Pub 2007. PMID: 17660828.
193. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56(7):1825-33, 2007. e-Pub 2007. PMID: 17456853.
194. Thompson, EW, Savagner, P, Dedhar, S, Kalluri, R. Epithelial-mesenchymal transitions - New insights into signaling, development and pathogenesis. Cells Tissues Organs 185(1-3):5-6, 2007. PMID: 17639611.
195. Garovic VD, Wagner SJ, Petrovic LM, Gray CE, Hall P, Sugimoto H, Kalluri R, Grande JP. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 22(4):1136-43, 2007. e-Pub 2007. PMID: 17255128.
196. Kalluri R, Shera CA. Near equivalence of human click-evoked and stimulus-frequency otoacoustic emissions. J Acoust Soc Am 121(4):2097-110, 2007. PMID: 17471725.
197. Teng Y, Zeisberg M, Kalluri R. Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest 117(2):304-6, 2007. PMID: 17273552.
198. Dandapani SV, Sugimoto H, Matthews BD, Kolb RJ, Sinha S, Gerszten RE, Zhou J, Ingber DE, Kalluri R, Pollak MR. Alpha-actinin-4 is required for normal podocyte adhesion. J Biol Chem 282(1):467-77, 2007. e-Pub 2006. PMID: 17082197.
199. Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH, Simon KJ, Chun Wang L, Leone DR, Lobb RR, McCrann DJ, Allaire NE, Horan GS, Fogo A, Kalluri R, Shield CF 3rd, Sheppard D, Gardner HA, Violette SM. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol 170(1):110-25, 2007. PMID: 17200187.
200. Sugimoto H, Yang C, LeBleu VS, Soubasakos MA, Giraldo M, Zeisberg M, Kalluri R. BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 21(1):256-64, 2007. e-Pub 2006. PMID: 17116741.
201. Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int 71(7):615-8, 2007. PMID: None.
202. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5(12):1640-6, 2006. e-Pub 2006. PMID: 17106243.
203. Kalluri R, Zeisberg E. Controlling angiogenesis in heart valves. Nat Med 12(10):1118-9, 2006. PMID: 17024200.
204. Kalluri R. Proteinuria with and without renal glomerular podocyte effacement. J Am Soc Nephrol 17(9):2383-9, 2006. PMID: 16914535.
205. Farazi PA, Zeisberg M, Glickman J, Zhang Y, Kalluri R, DePinho RA. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res 66(13):6622-7, 2006. PMID: 16818635.
206. Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A 103(19):7321-6, 2006. e-Pub 2006. PMID: 16648256.
207. Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF 3rd, Werb Z, Kalluri R. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 3(4):e100, 2006. e-Pub 2006. PMID: 16509766.
208. Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R, Shi GP. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281(9):6020-9, 2006. e-Pub 2005. PMID: 16365041.
209. MacDonald BA, Sund M, Grant MA, Pfaff KL, Holthaus K, Zon LI, Kalluri R. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome. Blood 107(5):1908-15, 2006. e-Pub 2005. PMID: 16254142.
210. Tanjore H, Kalluri R. The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol 168(3):715-7, 2006. PMID: 16507886.
211. Zeisberg M, Kramer K, Sindhi N, Sarkar P, Upton M, Kalluri R. De-differentiation of primary human hepatocytes depends on the composition of specialized liver basement membrane. Mol Cell Biochem 283(1-2):181-9, 2006. PMID: 16444601.
212. Sudhakar A, Nyberg P, Keshamouni VG, Mannam AP, Li J, Sugimoto H, Cosgrove D, Kalluri R. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 115(10):2801-10, 2005. e-Pub 2005. PMID: 16151532.
213. Reiser J, Polu KR, Moller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37(7):739-44, 2005. e-Pub 2005. PMID: 15924139.
214. Sund M, Maeshima Y, Kalluri R. Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion. Biochem J 387(Pt 3):755-61, 2005. PMID: 15598179.
215. Reynolds J, Prodromidi EI, Juggapah JK, Abbott DS, Holthaus KA, Kalluri R, Pusey CD. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 16(5):1350-9, 2005. e-Pub 2005. PMID: 15814836.
216. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280(9):8094-100, 2005. e-Pub 2004. PMID: 15591043.
217. Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A 102(8):2934-9, 2005. e-Pub 2005. PMID: 15710885.
218. Krishna TH, Mahipal S, Sudhakar A, Sugimoto H, Kalluri R, Rao KS. Reduced DNA gap repair in aging rat neuronal extracts and its restoration by DNA polymerase beta and DNA-ligase. J Neurochem 92(4):818-23, 2005. PMID: 15686483.
219. Zeisberg M, Soubasakos MA, Kalluri R. Animal models of renal fibrosis. Methods Mol Med 117(None):261-72, 2005. PMID: 16118458.
220. Benigni A, Gagliardini E, Tomasoni S, Abbate M, Ruggenenti P, Kalluri R, Remuzzi G. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 65(6):2193-200, 2004. PMID: 15149332.
221. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113(10):1390-7, 2004. PMID: 15146236.
222. Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R. Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression. Cancer Res 64(5):1570-4, 2004. PMID: 14996710.
223. Folkman J, Kalluri R. Cancer without disease. Nature 427(6977):787, 2004. PMID: 14985739.
224. Bhattacharya G, Kalluri R, Orten DJ, Kimberling WJ, Cosgrove D. A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure. J Cell Sci 117(Pt 2):233-42, 2004. PMID: 14676276.
225. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res 63(23):8312-7, 2003. PMID: 14678990.
226. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285(6):F1060-7, 2003. e-Pub 2003. PMID: 12915382.
227. Salama AD, Chaudhry AN, Holthaus KA, Mosley K, Kalluri R, Sayegh MH, Lechler RI, Pusey CD, Lightstone L. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 64(5):1685-94, 2003. PMID: 14531801.
228. McDonald GA, Sarkar P, Rennke H, Unemori E, Kalluri R, Sukhatme VP. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am J Physiol Renal Physiol 285(1):F59-67, 2003. PMID: 12820641.
229. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9(7):964-8, 2003. PMID: 12808448.
230. Gagliardini E, Benigni A, Tomasoni S, Abbate M, Kalluri R, Remuzzi G. Targeted downregulation of extracellular nephrin in human IgA nephropathy. Am J Nephrol 23(4):277-86, 2003. e-Pub 2003. PMID: 12853730.
231. Kos CH, Le TC, Sinha S, Henderson JM, Kim SH, Sugimoto H, Kalluri R, Gerszten RE, Pollak MR. Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest 111(11):1683-90, 2003. PMID: 12782671.
232. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3(6):589-601, 2003. PMID: 12842087.
233. Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J 17(8):860-8, 2003. PMID: 12724345.
234. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A 100(8):4766-71, 2003. e-Pub 2003. PMID: 12682293.
235. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278(15):12605-8, 2003. e-Pub 2003. PMID: 12538598.
236. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 124(1):147-59, 2003. PMID: 12512039.
237. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110(11):1659-66, 2002. PMID: 12464671.
238. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62(3):901-13, 2002. PMID: 12164872.
239. Hamano Y, Grunkemeyer JA, Sudhakar A, Zeisberg M, Cosgrove D, Morello R, Lee B, Sugimoto H, Kalluri R. Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 277(34):31154-62, 2002. e-Pub 2002. PMID: 12039968.
240. Natoli TA, Liu J, Eremina V, Hodgens K, Li C, Hamano Y, Mundel P, Kalluri R, Miner JH, Quaggin SE, Kreidberg JA. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13(8):2058-67, 2002. PMID: 12138137.
241. Bloom RD, O'Connor T, Cizman B, Kalluri R, Naji A, Madaio MP. Intrathymic kidney cells delay the onset of lupus nephritis in MRL-lpr/lpr mice. Int Immunol 14(8):867-71, 2002. PMID: 12147623.
242. Zeisberg M, Ericksen MB, Hamano Y, Neilson EG, Ziyadeh F, Kalluri R. Differential expression of type IV collagen isoforms in rat glomerular endothelial and mesangial cells. Biochem Biophys Res Commun 295(2):401-7, 2002. PMID: 12150963.
243. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 160(6):2001-8, 2002. PMID: 12057905.
244. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61(5):1714-28, 2002. PMID: 11967021.
245. Meyers KE, Allen J, Gehret J, Jacobovits A, Gallo M, Neilson EG, Hopfer H, Kalluri R, Madaio MP. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 61(5):1666-73, 2002. PMID: 11967016.
246. Reimer CL, Agata N, Tammam JG, Bamberg M, Dickerson WM, Kamphaus GD, Rook SL, Milhollen M, Fram R, Kalluri R, Kufe D, Kharbanda S. Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis. Cancer Res 62(3):789-95, 2002. PMID: 11830534.
247. Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295(5552):140-3, 2002. PMID: 11778052.
248. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 159(4):1313-21, 2001. PMID: 11583959.
249. Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM, Kalluri R. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem 276(34):31959-68, 2001. PMID: 11399763.
250. Okada H, Inoue T, Kanno Y, Kobayashi T, Ban S, Kalluri R, Suzuki H. Renal fibroblast-like cells in Goodpasture syndrome rats. Kidney Int 60(2):597-606, 2001. PMID: 11473642.
251. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 276(18):15240-8, 2001. PMID: 11278365.
252. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12(5):941-948, 2001. PMID: 11316852.
253. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7(4):811-22, 2001. PMID: 11336704.
254. Chugh S, Yuan H, Topham PS, Haydar SA, Mittal V, Taylor GA, Kalluri R, Salant DJ. Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum. Kidney Int 59(2):601-13, 2001. PMID: 11168941.
255. Kalluri R, Shera CA. Distortion-product source unmixing: a test of the two-mechanism model for DPOAE generation. J Acoust Soc Am 109(2):622-37, 2001. PMID: 11248969.
256. Chugh S, Yuan H, Topham PS, Haydar SA, Mittal V, Taylor GA, Kalluri R, Salant DJ. Aminopeptidase A: A nephritogenic target antigen of nephrotoxic serum. Kidney Int 59(2):601-13, 2001. PMID: None.
257. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12(5):941-8, 2001. PMID: None.
258. Karumanchi SA, Jha V, Ramchandran R, Karihaloo A, Tsiokas L, Chan B, Dhanabal M, Hanai JI, Venkataraman G, Shriver Z, Keiser N, Kalluri R, Zeng H, Mukhopadhyay D, Chen RL, Lander AD, Hagihara K, Yamaguchi Y, Sasisekharan R, Cantley L, Sukhatme VP. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 7(4):811-22, 2001. PMID: None.
259. Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM, Kalluri R. Extracellular matrix-derived peptide binds to αVβ3 integrin and inhibits angiogenesis. J Biol Chem 276(34):31959-68, 2001. PMID: None.
260. Okada H, Inoue T, Kanno Y, Kobayashi T, Ban S, Kalluri R, Suzuki H. Renal fibroblast-like cells in Goodpasture syndrome rats. Kidney Int 60(2):597-606, 2001. PMID: None.
261. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R. Renal fibrosis: Collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 159(4):1313-21, 2001. PMID: None.
262. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 276(18):15240-8, 2001. PMID: None.
263. Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res 60(24):6958-63, 2000. PMID: 11156396.
264. Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci A, Kalluri R. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 157(5):1649-59, 2000. PMID: 11073824.
265. Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J 6(5):287-93, 2000. PMID: 11079167.
266. Maeshima Y, Colorado PC, Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275(31):23745-50, 2000. PMID: 10837460.
267. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275(28):21340-8, 2000. PMID: 10766752.
268. Rutgers A, Meyers KE, Canziani G, Kalluri R, Lin J, Madaio MP. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int 58(1):115-22, 2000. PMID: 10886555.
269. Kalluri R, Cantley LG, Kerjaschki D, Neilson EG. Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J Biol Chem 275(26):20027-32, 2000. PMID: 10748075.
270. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60(9):2520-6, 2000. PMID: 10811134.
271. Kalluri R, Cosgrove D. Assembly of type IV collagen. Insights from alpha3(IV) collagen-deficient mice. J Biol Chem 275(17):12719-24, 2000. PMID: 10777566.
272. Okada H, Moriwaki K, Kalluri R, Imai H, Ban S, Takahama M, Suzuki H. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome. Kidney Int 57(3):927-36, 2000. PMID: 10720946.
273. Kalluri R, Torre A, Shield CF 3rd, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UM, van den Heuvel LP, Grossman R, Aradhye S, Neilson EG. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69(4):679-83, 2000. PMID: 10708133.
274. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275(2):1209-15, 2000. PMID: 10625665.
275. Okada H, Moriwaki K, Kalluri R, Takenaka T, Imai H, Ban S, Takahama M, Suzuki H. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. Am J Physiol Renal Physiol 278(1):F110-21, 2000. PMID: 10644662.
276. Okada H, Moriwaki K, Kalluri R, Imai H, Ban S, Takahama M, Suzuki H. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome. Kidney Int 57(3):927-36, 2000. PMID: None.
277. Kalluri R, Cosgrove D. Assembly of type IV collagen. Insights from α3(IV) collagen-deficient mice. J Biol Chem 275(17):12719-24, 2000. PMID: None.
278. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme, VP, Kalluri R. Canstatin: A novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275(2):1209-15, 2000. PMID: None.
279. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60(9):2520-6, 2000. PMID: None.
280. Okada H, Moriwaki K, Kalluri R, Takenaka T, Imai H, Ban S, Takahama M, Suzuki H. Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. Am J Physiol Renal Physiol 278(1):F110-21, 2000. PMID: None.
281. Cosgrove D, Rodgers K, Meehan D, Miller C, Bovard K, Gilroy A, Gardner H, Kotelianski V, Gotwals P, Amatucci A, Kalluri R. Integrin α1β1 and transforming growth factor-β1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 157(5):1649-59, 2000. PMID: None.
282. Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J 6(5):287-93, 2000. PMID: None.
283. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 275(28):21340-8, 2000. PMID: None.
284. Kalluri R, Cantley LG, Kerjaschki D, Neilson EG. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome. J Biol Chem 275(26):20027-32, 2000. PMID: None.
285. Kalluri R, Torre A, Shield CF III, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UM, vd Heuvel L, Grossman R, Aradhye S, Neilson EG. Identification of α3, α4 and α5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69(4):679-83, 2000. PMID: None.
286. Rutgers A, Meyers KE, Canziani G, Kalluri R, Lin J, Madaio MP. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients α3(IV)NC1 collagen. Kidney Int 58(1):115-22, 2000. PMID: None.
287. Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res 60(24):6958-63, 2000. PMID: None.
288. Maeshima Y, Colorado PC, Kalluri R. Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275(31):23745-50, 2000. PMID: None.
289. Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D. Role for transforming growth factor-beta1 in alport renal disease progression. Kidney Int 56(5):1662-73, 1999. PMID: 10571774.
290. Van Vliet AI, Van Alderwegen IE, Baelde HJ, de Heer E, Killen PD, Kalluri RK, Bruijn JA, Bergijk EC. Differential expression of collagen type IV alpha-chains in the tubulointerstitial compartment in experimental chronic serum sickness nephritis. J Pathol 189(2):279-87, 1999. PMID: 10547587.
291. Wolf G, Kalluri R, Ziyadeh FN, Neilson EG, Stahl RA. Angiotensin II induces alpha3(IV) collagen expression in cultured murine proximal tubular cells. Proc Assoc Am Physicians 111(4):357-64, 1999. PMID: 10417744.
292. Lei H, Kalluri R, Furth EE, Baker AH, Strauss JF 3rd. Rat amnion type IV collagen composition and metabolism: implications for membrane breakdown. Biol Reprod 60(1):176-82, 1999. PMID: 9858503.
293. Lei H, Furth EE, Kalluri R, Wakenell P, Kallen CB, Jeffrey JJ, Leboy PS, Strauss JF 3rd. Induction of matrix metalloproteinases and collagenolysis in chick embryonic membranes before hatching. Biol Reprod 60(1):183-9, 1999. PMID: 9858504.
294. Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D. Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int 56(5):1662-73, 1999. PMID: None.
295. Abbate M, Kalluri R, Corna D, Yamaguchi N, McCluskey RT, Hudson BG, Andres G, Zoja C, Remuzzi G. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen. Kidney Int 54(5):1550-61, 1998. PMID: 9844131.
296. Minto AW, Kalluri R, Togawa M, Bergijk EC, Killen PD, Salant DJ. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy. Proc Assoc Am Physicians 110(3):207-17, 1998. PMID: 9625527.
297. Bergijk EC, Van Alderwegen IE, Baelde HJ, de Heer E, Funabiki K, Miyai H, Killen PD, Kalluri RK, Bruijn JA. Differential expression of collagen IV isoforms in experimental glomerulosclerosis. J Pathol 184(3):307-15, 1998. PMID: 9614384.
298. Meyers KE, Kinniry PA, Kalluri R, Neilson EG, Madaio MP. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants. Kidney Int 53(2):402-7, 1998. PMID: 9461099.
299. Kalluri R, Gattone VH 2nd, Hudson BG. Identification and localization of type IV collagen chains in the inner ear cochlea. Connect Tissue Res 37(1-2):143-50, 1998. PMID: 9643653.
300. Kalluri R, Danoff TM, Okada H, Neilson EG. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100(9):2263-75, 1997. PMID: 9410904.
301. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273(4):F563-74, 1997. PMID: 9362334.
302. Tuori AJ, Virtanen I, Aine E, Kalluri R, Miner JH, Uusitalo HM. The immunohistochemical composition of corneal basement membrane in keratoconus. Curr Eye Res 16(8):792-801, 1997. PMID: 9255508.
303. Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander J, Kalluri R, Zhou J, Noelken ME, Hudson BG. Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of alpha3(IV) and alpha5(IV) chains. J Biol Chem 272(27):17023-32, 1997. PMID: 9202017.
304. Lohi J, Korhonen M, Leivo I, Kangas L, Tani T, Kalluri R, Miner JH, Lehto VP, Virtanen I. Expression of type IV collagen alpha1(IV)-alpha6(IV) polypeptides in normal and developing human kidney and in renal cell carcinomas and oncocytomas. Int J Cancer 72(1):43-9, 1997. PMID: 9212221.
305. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99(10):2470-8, 1997. PMID: 9153291.
306. Vargas MT, Gustilo K, D'Andrea DM, Kalluri R, Foster MH, Madaio MP. Structural features of nephritogenic lupus autoantibodies. Methods 11(1):62-9, 1997. PMID: 8990090.
307. Ortiz-Arduan A, Danoff TM, Kalluri R, Gonzalez-Cuadrado S, Karp SL, Elkon K, Egido J, Neilson EG. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 271(6 Pt 2):F1193-201, 1996. PMID: 8997393.
308. Lei H, Furth EE, Kalluri R, Chiou T, Tilly KI, Tilly JL, Elkon KB, Jeffrey JJ, Strauss JF 3rd. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 98(9):1971-8, 1996. PMID: 8903315.
309. Boutaud AA, Kalluri R, Kahsai TZ, Noelken ME, Hudson BG. Goodpasture syndrome: selective removal of anti-alpha 3 (IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresis. Exp Nephrol 4(4):205-12, 1996. PMID: 8864724.
310. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG. Coordinate gene expression of the alpha3, alpha4, and alpha5 chains of collagen type IV. Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271(23):13821-8, 1996. PMID: 8662866.
311. Kalluri R, Sun MJ, Hudson BG, Neilson EG. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen. J Biol Chem 271(15):9062-8, 1996. PMID: 8621555.
312. Merkel F, Kalluri R, Marx M, Enders U, Stevanovic S, Giegerich G, Neilson EG, Rammensee HG, Hudson BG, Weber M. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int 49(4):1127-33, 1996. PMID: 8691734.
313. Kalluri R, Melendez E, Rumpf KW, Sattler K, Muller GA, Strutz F, Neilson EG. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Proc Assoc Am Physicians 108(2):134-9, 1996. PMID: 8705733.
314. Peissel B, Geng L, Kalluri R, Kashtan C, Rennke HG, Gallo GR, Yoshioka K, Sun MJ, Hudson BG, Neilson EG, et al.. Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96(4):1948-57, 1995. PMID: 7560087.
315. Kalluri R, van den Heuvel LP, Smeets HJ, Schroder CH, Lemmink HH, Boutaud A, Neilson EG, Hudson BG. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 47(4):1199-204, 1995. PMID: 7783419.
316. Kalluri R, Gattone VH 2nd, Noelken ME, Hudson BG. The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc Natl Acad Sci U S A 91(13):6201-5, 1994. PMID: 8016138.
317. Ding J, Kashtan CE, Fan WW, Kleppel MM, Sun MJ, Kalluri R, Neilson EG, Michael AF. A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen. Kidney Int 45(5):1504-6, 1994. PMID: 8072264.
318. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45(3):721-6, 1994. PMID: 8196274.
319. Noelken ME, Reddy GK, Kalluri R, Gunwar S, Hudson BG. The chain composition of aorta basement membrane collagen IV, localization of the chains in aorta and supramolecular assembly of the collagen IV protomers. Contrib Nephrol 107(None):216-9, 1994. PMID: 8004971.
320. Reddy GK, Gunwar S, Kalluri R, Hudson BG, Noelken ME. Structure and composition of type IV collagen of bovine aorta. Biochim Biophys Acta 1157(3):241-51, 1993. PMID: 8323954.
321. Neilson EG, Kalluri R, Sun MJ, Gunwar S, Danoff T, Mariyama M, Myers JC, Reeders ST, Hudson BG. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 268(12):8402-5, 1993. PMID: 8473281.
322. Mariyama M, Kalluri R, Hudson BG, Reeders ST. The alpha 4(IV) chain of basement membrane collagen. Isolation of cDNAs encoding bovine alpha 4(IV) and comparison with other type IV collagens. J Biol Chem 267(2):1253-8, 1992. PMID: 1370461.
323. Kalluri R, Gunwar S, Reeders ST, Morrison KC, Mariyama M, Ebner KE, Noelken ME, Hudson BG. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen. J Biol Chem 266(35):24018-24, 1991. PMID: 1721062.
324. Gunwar S, Ballester F, Kalluri R, Timoneda J, Chonko AM, Edwards SJ, Noelken ME, Hudson BG. Glomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem 266(23):15318-24, 1991. PMID: 1869555.
325. Gunwar S, Bejarano PA, Kalluri R, Langeveld JP, Wisdom BJ Jr, Noelken ME, Hudson BG. Alveolar basement membrane: molecular properties of the noncollagenous domain (hexamer) of collagen IV and its reactivity with Goodpasture autoantibodies. Am J Respir Cell Mol Biol 5(2):107-12, 1991. PMID: 1892641.

Invited Articles

1. Vickman RE, Faget DV, Beachy P, Beebe D, Bhowmick NA, Cukierman E, Deng WM, Granneman JG, Hildesheim J, Kalluri R, Lau KS, Lengyel E, Lundeberg J, Moscat J, Nelson PS, Pietras K, Politi K, Puré E, Scherz-Shouval R, Sherman MH, Tuveson D, Weeraratna AT, White RM, Wong MH, Woodhouse EC, Zheng Y, Hayward SW, Stewart SA. Deconstructing tumor heterogeneity: The stromal perspective. Oncotarget 11(40):3621-3632, 2020. e-Pub 2020. PMID: 33088423.
2. Lebleu V, Kalluri R. Blocking PDGFR signaling reduces myofibroblasts and attenuates renal fibrosis. Kidney Int 80(11):1119-21, 2011. PMID: None.
3. Tse JC, Kalluri R. Waking up dormant tumors. Breast Cancer Res 13(3):310, 2011. PMID: None.
4. Wiig H, Keskin, D, Kalluri R. Interaction between the extracellular matrix and lymphatics: consequences for lymphanogiogenesis and lymphatic function. Matrix Biology 29(8):645-56, 2010. e-Pub 2010. PMID: None.
5. Hertig A, Flier SN, Kalluri R. Contribution of epithelial plasticity to renal transplantation-associated fibrosis. Transplant Proc 42(Suppl 9):S7-12, 2010. PMID: None.
6. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225(3):631-7, 2010. PMID: None.
7. Shenoy V, Kanasaki K, Kalluri R. Pre-eclampsia: Connecting angiogenic and metabolic pathways. Trends Endocrinol Metab 21(9):529-36, 2010. PMID: None.
8. Nataraj D, Ernst A, Kalluri R. Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition. Am J Respir Cell Mol Biol 43(2):129-30, 2010. PMID: None.
9. Keskin D, Kalluri R. NF-ĸB-induced chromatin remodeling regulates angiogenesis. Blood 116(3):312-3, 2010. PMID: None.
10. Force T, Bonow RO, Houser SR, Solaro RJ, Hershberger RE, Adhikari B, Anderson ME, Boineau R, Byrne BJ, Cappola TP, Kalluri R, LeWinter MM, Maron MS, Molkentin JD, Ommen SR, Regnier M, Tang WH, Tian R, Konstam MA, Maron BJ, Seidman CE. Research priorities in hypertrophic cardiomyopathy: Report of a working group of the National Heart, Lung, and Blood Institute. Circulation 122(11):1130-3, 2010. PMID: None.
11. Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2(11):a003244, 2010. PMID: None.
12. Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R. Interstitial fluid: The overlooked component of the tumor microenvironment?. Fibrogenesis Tissue Repair 23(3 (1)):12, 2010. PMID: None.
13. Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts. Circ Res 107(11):1304-12, 2010. PMID: None.
14. Lee SB, Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int 78(Suppl 119):S22-6, 2010. PMID: None.
15. Eikesdal HP, Kalluri R. Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol 19(5):310-7, 2009. PMID: None.
16. Duncan MB, Kalluri R. Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis. Mol Interv 9(4):168-70, 2009. PMID: None.
17. Sund M, Kalluri R. Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev 28(1-2):177-83, 2009. PMID: None.
18. Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney Int 76(8):831-7, 2009. PMID: None.
19. Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 175(4):1371-3, 2009. PMID: None.
20. Lee SB, Kanasaki K, Kalluri R. Circulating TGF-β1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int 76(1):10-2, 2009. PMID: None.
21. Ayala F, Dewar R, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23(12):2233-41, 2009. PMID: None.
22. Romagnani P, Kalluri R. Possible mechanisms of kidney repair. Fibrogenesis Tissue Repair 26(2(1)):3, 2009. PMID: None.
23. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420-8, 2009. PMID: None.
24. Kalluri R. EMT: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119(6):1417-9, 2009. PMID: None.
25. Duncan M, Kalluri R. Basement membrane derived inhibitors of angiogenesis. Angiogenesis: An Integrative Approach From Science to Medicine None(None):121-217, 2008. PMID: None.
26. LeBleu VS, Kalluri R. Stem cell-based therapy for glomerular diseases: An evolving concept. J Am Soc Nephrol 19(9):1621-3, 2008. PMID: None.
27. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res 68(23):9574-7, 2008. PMID: None.
28. Kalluri R, Kanasaki K. RNA interference: Generic block on angiogenesis. Nature 452(7187):543-5, 2008. PMID: None.
29. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. British Journal of Cancer 99(9):1375-9, 2008. PMID: None.
30. Reddy S, Kalluri R. Alport syndrome. Benner and Rector Book on Genetic Kidney Diseases:151-171, 2007. PMID: None.
31. Sund M, Kalluri R. Endogenous inhibitors of angiogenesis. Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy:215-231, 2007. PMID: None.
32. Teng Y, Zeisberg M, Kalluri R. Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest 117(2):304-306, 2007. PMID: None.
33. Tse J, and Kalluri R. Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem 101(4):816-29, 2007. PMID: None.
34. Mundel T, Kalluri R. Type IV collagen-derived angiogenesis inhibitors. Microvascular Research 74(2-3):85-89, 2007. PMID: None.
35. LeBleu V, MacDonald M, Kalluri R. Structure and function of basement membranes. Exp Biol Med 232(9):1121-9, 2007. PMID: None.
36. Folkman J, Heymach J, Kalluri R. Tumor angiogenesis. Cancer Medicine(7th Edition):157-191, 2006. PMID: None.
37. Kalluri R. Proteinuria with and without renal glomerular podocyte effacement. J Am Soc Nephrol 17(9):2383-9, 2006. PMID: None.
38. Tanjore H, Kalluri R. The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol 168(3):715-7, 2006. PMID: None.
39. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nature Rev Cancer 6(5):392-401, 2006. PMID: None.
40. Lee J, Dedhar S, Kalluri R, Thompson E. The epithelial-mesenchymal transition: New insights in signalling, development and disease. J. Cell Bio 172(7):973-81, 2006. PMID: None.
41. Kalluri R, Zeisberg E. Controlling angiogenesis in heart valves. Nat Med 12:1118-1119, 2006. PMID: None.
42. Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Research 65:10, 2005. PMID: None.
43. Kalluri R, Grant MA. Structure-function analysis of endogenous inhibitors of angiogenesis. Cold Spring Harbor Symposia on Controlling Cancer 70:1-12, 2005. PMID: None.
44. Okada H, Kalluri R. Recapitulation of kidney development paradigms by BMP-7 reverses chronic renal injury. Clin Exp Nephrol 9(2):100-1, 2005. PMID: None.
45. Hamano Y, Kalluri R. Tumstatin as an angiogenesis inhibitor and tumor suppressor. Biochem Biophys Res Commun 333:292-98, 2005. PMID: None.
46. Okada H, and Kalluri R. Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. Curr Mol Med 5(5):467-74, 2005. PMID: None.
47. Zeisberg M, Kalluri R. Experimental strategies to reverse chronic renal failure. Blood Purification 22(5):440-5, 2004. PMID: None.
48. Folkman J, Kalluri R. Cancer without disease. Nature 427:785, 2004. PMID: None.
49. Sund M, Xie L, Kalluri R. The contribution of vascular basement membranes and extracellular matrix in the mechanics of tumor angiogenesis. APMIS 112(7-8):450-62, 2004. PMID: None.
50. Zeisberg M, Müller G, Kalluri R. Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrology Dialysis Transplantation 19(4):759-61, 2004. PMID: None.
51. Zeisberg M, Kalluri R. The role of epithelial-to mesenchymal-transition in renal fibrosis. J Mol Med 82(3):175-81, 2004. PMID: None.
52. Kalluri R. Basement membranes: Structural features, assembly, cellular interactions and role in cancer angiogenesis. Nature Rev Cancer 3(6):422-33, 2003. PMID: None.
53. Kalluri R, Zeisberg M. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7. Histology and Histopathology 18(1):217-24, 2003. PMID: None.
54. Folkman J, Kalluri R. Tumor angiogenesis. Cancer Medicine(6th), 2002. PMID: None.
55. Kalluri R. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol 67:255-66, 2002. PMID: None.
56. Kalluri R, Sukhatme VP. Matrix associated endogenous inhibitors of angiogenesis. Tumor Angiogenesis and Microcirculation:375-385, 2001. PMID: None.
57. Kalluri R, Sukhatme VP. Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 9(4):413-8, 2000. PMID: None.
58. Meyers CM, Kalluri R, Neilson EG. Anti-basement membrane antibodies in Goodpasture syndrome. Immunologic Renal Diseases:959-73, 1997. PMID: None.
59. Ziyadeh FN, Mogyorosi A, Kalluri R. Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol 5(1):2-9, 1997. PMID: None.
60. D’Andrea D, Meyers K, Kalluri R, Madaio MP. Glomerular and renal parenchymal diseases. Curr Nephrol 20:179-208, 1996. PMID: None.

Other Articles

1. Kalluri, R The biology and function of extracellular vesicles in immune response and immunity. Immunity 57(8):1752-1768, 2024. PMID: 39142276.
2. McAndrews KM, Mahadevan KK, Kalluri R Mouse Models to Evaluate the Functional Role of the Tumor Microenvironment in Cancer Progression and Therapy Responses. Cold Spring Harb Perspect Med 14(7), 2024. PMID: 38191175.
3. Kalluri R, McAndrews KM The role of extracellular vesicles in cancer. Cell 186(8):1610-1626, 2023. PMID: 37059067.
4. Chen Y, McAndrews KM, Kalluri R Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol 18(12):792-804, 2021. PMID: 34489603.
5. Kugeratski FG, McAndrews KM, Kalluri R Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer. Endocrinology 162(3), 2021. PMID: 33411885.
6. Kugeratski FG, Kalluri R Exosomes as mediators of immune regulation and immunotherapy in cancer. FEBS J 288(1):10-35, 2021. PMID: 32910536.
7. Chronopoulos A, Kalluri R Emerging role of bacterial extracellular vesicles in cancer. Oncogene 39(46):6951-6960, 2020. PMID: 33060855.
8. Xunian Z, Kalluri R Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci 111(9):3100-3110, 2020. PMID: 32639675.
9. LeBleu VS, Kalluri R Exosomes as a Multicomponent Biomarker Platform in Cancer. Trends Cancer 6(9):767-774, 2020. PMID: 32307267.
10. Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, Garcia de Herreros A, Goodall GJ, Hadjantonakis AK, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massague J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP, Sheng G Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 21(6):341-352, 2020. PMID: 32300252.
11. Kalluri R, LeBleu VS The biology, function, and biomedical applications of exosomes. Science 367(6478):None, 2020. PMID: 32029601.
12. Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R, Kshitiz Systems Biology of Cancer Metastasis. Cell Syst 9(2):109-127, 2019. PMID: 31465728.
13. McAndrews KM, Kalluri R Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer 18(1):52, 2019. PMID: 30925917.
14. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Bock BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquiere B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21(3):425-532, 2018. PMID: 29766399.
15. LeBleu VS, Kalluri R A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech 11(4):None, 2018. PMID: 29686035.
16. Kurywchak P, Tavormina J, Kalluri R The emerging roles of exosomes in the modulation of immune responses in cancer. Genome Med 10(1):23, 2018. PMID: 29580275.
17. Lovisa S, Zeisberg M, Kalluri R Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis. Trends Endocrinol Metab 27(10):681-695, 2016. PMID: 27372267.
18. Kalluri R The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582-98, 2016. PMID: 27550820.
19. Kalluri R The biology and function of exosomes in cancer. J Clin Invest 126(4):1208-15, 2016. PMID: 27035812.
20. Kalluri R, LeBleu VS Discovery of Double-Stranded Genomic DNA in Circulating Exosomes. Cold Spring Harb Symp Quant Biol 81(None):275-280, 2016. PMID: 28424339.
21. Zeisberg M, Kalluri R Physiology of the Renal Interstitium. Clin J Am Soc Nephrol 10(10):1831-40, 2015. PMID: 25813241.
22. LeBleu, V, O'Connell, JT, Herrera, KN, Wikman, H, Pantel, K, Haigis, MC, De Carvalho, FH, Damascena, AS, Chinen, LT, Rocha, RM, Asara, JM, Kalluri, R Erratum. Nature cell biology 16(11):1125, 2014. PMID: None.
23. Kanasaki, K, Yu, W, Von Bodungen, M, Larigakis, JD, Kanasaki, M, Ayala, F, Kalluri, R, Hill, WG Re. Journal of Urology 190(6):2305, 2013. PMID: 24209569.
24. Kahlert C, Kalluri R Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 91(4):431-7, 2013. PMID: 23519402.
25. Zeisberg M, Kalluri R Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 304(3):C216-25, 2013. PMID: 23255577.
26. Kieran MW, Kalluri R, Cho YJ The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med 2(12):a006593, 2012. PMID: 23209176.
27. Medici D, Kalluri R Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol 22(5-6):379-84, 2012. PMID: 22554794.
28. Melo SA, Kalluri R Molecular pathways: microRNAs as cancer therapeutics. Clin Cancer Res 18(16):4234-9, 2012. PMID: 22711704.
29. Tse JC, Kalluri R Waking up dormant tumors. Breast Cancer Res 13(3):310, 2011. PMID: 21672272.
30. Medici, D, Shore, EM, Lounev, VY, Kaplan, FS, Kalluri, R, Olsen, BR Erratum. Nature medicine 17(4):514, 2011. PMID: None.
31. Lee SB, Kalluri R Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 78(119):S22-6, 2010. PMID: 21116313.
32. Zeisberg EM, Kalluri R Origins of cardiac fibroblasts. Circ Res 107(11):1304-12, 2010. PMID: 21106947.
33. Polyak K, Kalluri R The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2(11):a003244, 2010. PMID: 20591988.
34. Krenning G, Zeisberg EM, Kalluri R The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225(3):631-7, 2010. PMID: 20635395.
35. Hertig A, Flier SN, Kalluri R Contribution of epithelial plasticity to renal transplantation-associated fibrosis. Transplant Proc 42(9 Suppl):S7-12, 2010. PMID: 21095454.
36. Wiig H, Keskin D, Kalluri R Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function. Matrix Biol 29(8):645-56, 2010. PMID: 20727409.
37. Shenoy V, Kanasaki K, Kalluri R Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab 21(9):529-36, 2010. PMID: 20646932.
38. Kalluri, R, Weinberg, RA Erratum. Journal of Clinical Investigation 120(5):1786, 2010. PMID: None.
39. Hertig A, Gangadhar T, Kalluri R Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. J Mol Cell Cardiol 48(3):497-503, 2010. PMID: 19646990.
40. Ayala F, Dewar R, Kieran M, Kalluri R Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia 23(12):2233-41, 2009. PMID: 19727127.
41. Eikesdal HP, Kalluri R Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol 19(5):310-7, 2009. PMID: 19524042.
42. Kanasaki K, Kalluri R The biology of preeclampsia. Kidney Int 76(8):831-7, 2009. PMID: 19657323.
43. Kalluri R, Weinberg RA The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420-8, 2009. PMID: 19487818.
44. Sund M, Kalluri R Tumor stroma derived biomarkers in cancer. Cancer Metastasis Rev 28(1-2):177-83, 2009. PMID: 19259624.
45. Kalluri R EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119(6):1417-9, 2009. PMID: 19487817.
46. Potenta S, Zeisberg E, Kalluri R The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 99(9):1375-9, 2008. PMID: 18797460.
47. Eatock RA, Xue J, Kalluri R Ion channels in mammalian vestibular afferents may set regularity of firing. J Exp Biol 211(Pt 11):1764-74, 2008. PMID: 18490392.
48. Nyberg P, Salo T, Kalluri R Tumor microenvironment and angiogenesis. Front Biosci 13(None):6537-53, 2008. PMID: 18508679.
49. LeBleu VS, Macdonald B, Kalluri R Structure and function of basement membranes. Exp Biol Med (Maywood) 232(9):1121-9, 2007. PMID: 17895520.
50. Mundel TM, Kalluri R Type IV collagen-derived angiogenesis inhibitors. Microvasc Res 74(2-3):85-9, 2007. PMID: 17602710.
51. Tse JC, Kalluri R Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101(4):816-29, 2007. PMID: 17243120.
52. Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int 71(7):615-8, 2007. PMID: 17290292.
53. Kalluri R, Zeisberg M Fibroblasts in cancer. Nat Rev Cancer 6(5):392-401, 2006. PMID: 16572188.
54. Lee JM, Dedhar S, Kalluri R, Thompson EW The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973-81, 2006. PMID: 16567498.
55. Sund M, Zeisberg M, Kalluri R Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application. Gastroenterology 129(6):2076-91, 2005. PMID: 16344073.
56. Zehnder AF, Adams JC, Santi PA, Kristiansen AG, Wacharasindhu C, Mann S, Kalluri R, Gregory MC, Kashtan CE, Merchant SN Distribution of type IV collagen in the cochlea in Alport syndrome. Arch Otolaryngol Head Neck Surg 131(11):1007-13, 2005. PMID: 16301374.
57. Okada H, Kalluri R Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis. Curr Mol Med 5(5):467-74, 2005. PMID: 16101477.
58. Hamano Y, Kalluri R Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun 333(2):292-8, 2005. PMID: 15979458.
59. Okada H, Kalluri R Recapitulation of kidney development paradigms by BMP-7 reverses chronic renal injury. Clin Exp Nephrol 9(2):100-1, 2005. PMID: 15980942.
60. Nyberg P, Xie L, Kalluri R Endogenous inhibitors of angiogenesis. Cancer Res 65(10):3967-79, 2005. PMID: 15899784.
61. Charytan D, MacDonald B, Sugimoto H, Pastan S, Staton G, Hennigar R, Kalluri R An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies. Am J Kidney Dis 45(4):743-8, 2005. PMID: 15806477.
62. Grant MA, Kalluri R Structural basis for the functions of endogenous angiogenesis inhibitors. Cold Spring Harb Symp Quant Biol 70:399-410, 2005. PMID: 16869777.
63. Sund M, Xie L, Kalluri R The contribution of vascular basement membranes and extracellular matrix to the mechanics of tumor angiogenesis. APMIS 112(7-8):450-62, 2004. PMID: 15563309.
64. Charytan D, Torre A, Khurana M, Nicastri A, Stillman IE, Kalluri R Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome. J Nephrol 17(3):431-5, 2004. PMID: 15365966.
65. Zeisberg M, Kalluri R The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) 82(3):175-81, 2004. PMID: 14752606.
66. Zeisberg M, Kalluri R Experimental strategies to reverse chronic renal disease. Blood Purif 22(5):440-5, 2004. PMID: 15359103.
67. Kalluri R, Neilson EG Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112(12):1776-84, 2003. PMID: 14679171.
68. Charytan DM, Le DD, Grossman JM, Holthaus KA, Kalluri R Antiglomerular basement membrane autoantibodies are nonpathogenic in Wegener's granulomatosis. Am J Med 115(5):414-5, 2003. PMID: 14553885.
69. Kalluri R Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3(6):422-33, 2003. PMID: 12778132.
70. Kalluri R, Zeisberg M Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7. Histol Histopathol 18(1):217-24, 2003. PMID: 12507301.
71. Kalluri R Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol 67:255-66, 2002. PMID: 12858548.
72. Kalluri R, Sukhatme VP Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 9(4):413-8, 2000. PMID: 10926178.
73. Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Neilson EG Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol 8(11):1795-800, 1997. PMID: 9355084.
74. Kalluri R, Petrides S, Wilson CB, Tomaszewski JE, Palevsky HI, Grippi MA, Madaio MP, Neilson EG Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann Intern Med 124(7):651-3, 1996. PMID: 8607593.
75. Okada H, Strutz F, Danoff TM, Kalluri R, Neilson EG Possible mechanisms of renal fibrosis. Contrib Nephrol 118(None):147-54, 1996. PMID: 8744052.
76. Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6(4):1178-85, 1995. PMID: 8589284.
77. Hudson BG, Kalluri R, Tryggvason K Pathology of glomerular basement membrane nephropathy. Curr Opin Nephrol Hypertens 3(3):334-9, 1994. PMID: 7922261.
78. Kalluri, R, Gattone, VH, Noelken, ME, Hudson, BG Erratum. Proceedings of the National Academy of Sciences of the United States of America 91(19):9195, 1994. PMID: None.
79. Hudson BG, Kalluri R, Gunwar S, Noelken ME Structure and organization of type IV collagen of renal glomerular basement membrane. Contrib Nephrol 107(None):163-7, 1994. PMID: 8004963.
80. Hudson BG, Kalluri R, Gunwar S, Noelken ME, Mariyama M, Reeders ST Molecular characteristics of the Goodpasture autoantigen. Kidney Int 43(1):135-9, 1993. PMID: 7679455.
81. Hudson BG, Kalluri R, Gunwar S, Weber M, Ballester F, Hudson JK, Noelken ME, Sarras M, Richardson WR, Saus J, et al. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42(1):179-87, 1992. PMID: 1635348.

Editorials

1. Zeisberg M, Kalluri R. The Kielin/chordin-like protein checkpoint constitutes a system of checks and balances in CKD. J Am Soc Nephrol 24(6):863-5, 2013. PMID: 23687357.
2. Nataraj D, Ernst A, Kalluri R. Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition. Am J Respir Cell Mol Biol 43(2):129-30, 2010. PMID: 20651063.
3. Zeisberg M, Kalluri R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol 23(9):1395-8, 2008. PMID: 18446379.
4. LeBleu VS, Kalluri R. Stem cell-based therapy for glomerular diseases: an evolving concept. J Am Soc Nephrol 19(9):1621-3, 2008. PMID: 18701605.
5. Zeisberg M, Muller GA, Kalluri R. Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant 19(4):759-61, 2004. PMID: 15031324.
6. Kalluri R. Goodpasture syndrome. Kidney Int 55(3):1120-2, 1999. PMID: 10027952.
7. Ziyadeh FN, Mogyorosi A, Kalluri R. Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol 5(1):2-9, 1997. PMID: 9052842.

Book Chapters

1. Kugeratski, FG, Kalluri, R. Exploiting Exosomes for Cancer Diagnosis and Treatment, 43-59, 2023.
2. Brønnum, BH, Kalluri, R. Cardiac Fibrosis, 389-404, 2012.
3. Sudhakar, A, Kalluri, R. Molecular mechanisms of angiostasis, 52-59, 2010.
4. Lu, L, Harikrishna, T, Kalluri, R. Discovery of extracellular matrix degradome as novel endogenous regulators of angiogenesis and tumor growth, 191-202, 2009.
5. Sund, M, Kalluri, R. Endogenous inhibitors of angiogenesis, 215-231, 2008.
6. Keithi-Reddy, SR, Kalluri, R. Molecular and genetic basis of alport syndrome, 151-171, 2008.
7. Duncan, MB, Kalluri, R. Basement membrane derived inhibitors of angiogenesis, 121-127, 2008.
8. Keithi-Reddy, SR, Kalluri, R. Molecular and genetic basis of alport syndrome, 151-171, 2007.

Letters to the Editor

1. Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R. Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3. Nat Med 19: 810-1, 2013.